E.coli-derived human ZNT8/SLC30A recombinant protein (Position: M1-C361). Human ZNT8/SLC30A shares 80.6% and 78.1% amino acid (aa) sequence identity with mouse and rat ZNT8/SLC30A, respectively.
Each vial contains 50% glycerol, 0.9% NaCl, 0.2% Na2HPO4.
Purity:
Immunogen affinity purified.
Form:
Liquid
Target:
Proton-coupled zinc antiporter SLC30A8
Application Dilute:
Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
* VAT and and shipping costs not included. Errors and price changes excepted